Explore the importance of GMP-grade plasmid DNA (pDNA) in cell and gene therapies, the challenges in global supply, and how ...

The Board of 4basebio plc is pleased to report the results for the financial year ended 31 December 2024. The annual report and accounts together with a notice of the Company’s annual general meeting, ...

4basebio reported strong progress for the year ended 31 December on Tuesday, with revenue doubling from DNA sales to £0.93m ...

In addition to complementing AAV manufacturing, the company’s Plasmid DNA (pDNA) platform is now available as a standalone ...

VGXI, Inc., a leading contract development and manufacturing organization (CDMO) specializing in plasmid DNA biopharmaceuticals, including for use in gene therapies, DNA vaccines, and RNA medicines, ...

GEN talked with several contract development and manufacturing organizations (CDMOs) and/or contract research organizations (CROs) about new ways they are addressing AAV manufacturing challenges.

Researchers found that flight attendants show reduced DNA repair capacity and immune changes after air travel, which may help ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving ...

IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that it has filed a request for withdrawal with the Securities and ...

The Business Research Company’s Phosphoramidite Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 15, 2025 /EINPresswire.com/ -- The ...

Results further validate PlaCCine as a novel vaccine platform with potential applications in COVID-19 and other infectious diseases with epidemic implications “It is very encouraging to see strong ...